EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseStudienprotokollOpen Access · CC BY 4.0

Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol

Lishi Liu iD, Zihan Meng, Jun Yan iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0318984 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS ONE, 2025. Verfasst von Lishi Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Acupuncture Therapy, Chemotherapy-Related Cognitive Impairment, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy-related cognitive impairment (CRCI) is a common adverse effect of chemotherapy in breast cancer patients, with a high incidence that significantly impacts treatment adherence and quality of life. Currently, there is no definitive and effective treatment for CRCI. Research indicates that acupuncture may serve as a promising intervention for CRCI. This study aims to assess the effectiveness of acupuncture in treating CRCI.

Methods

This study is guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P). From the time of database construction to October 2024, we will search seven literature databases, three clinical study registry databases, and three sources of gray literature. The restricted languages are English and Chinese. We will use the Participants-Interventions-Comparators-Outcome-Conclusion-Study Design (PICOS) criteria to identify included studies and the RoB2 tool to assess the quality of the included studies. Data synthesis and meta-analysis will be performed using RevMan 5.3.

Discussion

The results of this study will clarify the potential benefits of acupuncture in the treatment of CRCI and address existing disagreements about its efficacy. Furthermore, the findings will assist clinicians in making informed decisions regarding the treatment of CRCI. Trail registration PROSPERO registration number: CRD42024568093 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAcupuncture TherapyChemotherapy-Related Cognitive ImpairmentAntineoplastic AgentsCognitive DysfunctionHumansSystematic Reviews as TopicFemaleMeta-Analysis as TopicQuality of LifeTreatment Outcome

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

ORCID-Profile: Lishi Liu, Jun Yan

Zitieren

APA

Liu, L., Meng, Z., & Yan, J. (2025). Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0318984

Vancouver

Liu L, Meng Z, Yan J. Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol. PLOS ONE. 2025. doi:10.1371/journal.pone.0318984

BibTeX
@article{Liu2025,
  author = {Liu, Lishi and Meng, Zihan and Yan, Jun},
  title = {Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0318984}
}
Kostenlos starten →